YSB (HKSE:09885) FCF Yield % : 8.69 (As of Jun. 17, 2024)

View and export this data going back to 2023. Start your Free Trial

What is YSB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, YSB's Trailing 12-Month Free Cash Flow is HK$474 Mil, and Market Cap is HK$5,461 Mil. Therefore, YSB's FCF Yield % for today is 8.69%.

The historical rank and industry rank for YSB's FCF Yield % or its related term are showing as below:

HKSE:09885' s FCF Yield % Range Over the Past 10 Years
Min: 0.15 Med: 1.17 Max: 19.08
Current: 8.69

During the past 4 years, the highest FCF Yield % of YSB was 19.08%. The lowest was 0.15%. And the median was 1.17%.

HKSE:09885's FCF Yield % is ranked better than
81.41% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 0.45 vs HKSE:09885: 8.69

YSB's FCF Margin % for the quarter that ended in Dec. 2023 was 0.84%.

YSB FCF Yield % Historical Data

The historical data trend for YSB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB FCF Yield % Chart

YSB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

8.99

YSB Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial			-	-	-	6.09	3.15

Competitive Comparison of YSB's FCF Yield %

For the Pharmaceutical Retailers subindustry, YSB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YSB's FCF Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where YSB's FCF Yield % falls into.

YSB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

YSB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	474.32	/	5277.5964
	=	8.99%

YSB's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	83.195	*	2	/	5277.5964
	=	3.15%

YSB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

YSB FCF Yield % Related Terms

Thank you for viewing the detailed overview of YSB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

YSB (HKSE:09885) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN

Website

https://www.ysbang.cn

YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.

Executives

Chu Mang Yee	2201 Interest of corporation controlled by you
Meta Group Limited	2201 Interest of corporation controlled by you
Sounda Properties Limited	2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.	2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Chen Xiaohong	2201 Interest of corporation controlled by you
H Capital V Gp, L.p.	2201 Interest of corporation controlled by you
H Capital V Gp, Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Miyt Holdings Limited	2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines